• Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

  • Dec 6 2023
  • Length: 29 mins
  • Podcast

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

  • Summary

  • Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial carcinoma. Single-agent immunotherapies (pembrolizumab and dostarlimab), and now immunotherapy and antiangiogenic therapy combinations (pembrolizumab and lenvatinib), are transforming treatment pathways, with OS benefits in the second-line now achievable. They offer tips for managing the toxicity of these novel therapeutic options and set the stage for 2023, a year which promises a paradigm shift in the use of systemic treatments in this once underserved malignancy.

    Show More Show Less
activate_samplebutton_t1

What listeners say about Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.